Exodus Point Capital Management, LP Cabaletta Bio, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$16.79 - $25.38 $895,612 - $1.35 Million	53,342 New	53,342 $910,000
Q1 2022 May 13, 2022	SELL	$1.68 - $3.92 $17,495 - $40,822	-10,414 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.36 - $14.64 $34,991 - $152,460	10,414 New	10,414 $39,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $236,999 - $423,212	-33,857 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.2 - $11.73 $243,770 - $397,142	33,857 New	33,857 $291,000
Q2 2020 Aug 14, 2020	SELL	$6.39 - $11.28 $100,118 - $176,735	-15,668 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.0 - $18.67 $94,008 - $292,521	15,668 New	15,668 $114,000

146

50.2M

19.9K

41.5K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $127M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.